johnson &amp johnson janssen cilag unit to reduce work force janssen cilag will eliminate jobs the belgian pharmaceutical maker said as it seeks to put more money into research and development and as exclusive patent rights to top selling drugs expire the job cuts come less than two months after u s parent company johnson &amp johnson said it would reduce its global work force by as much as as many as jobs because of slumping sales of heart stents and looming patent expirations janssen employs people in belgium and more than a thousand elsewhere 
